We are live on !
Find out more
Capula Management Portfolio holdings
AUM
$28B
Turnover
51.43%
1-Year Est. Return
22.67%
This Fund
S&P 500
This Quarter Est. Return
+16.2%
1 Year Est. Return
+22.67%
3 Year Est. Return
+90.67%
5 Year Est. Return
+93.79%
10 Year Est. Return
+167.22%
AUM
$28B
AUM Growth
+$13.9B
(+99%)
Cap. Flow
+$13.1B
Cap. Flow % of AUM
Cap. Flow %
46.94%
Top 10 Holdings %
Top 10 Hldgs %
73.32%
Holding
1,190
New
122
Increased
162
Reduced
335
Closed
490
Avg Time Held
Equity + Options
0.8
years
Top 10 Avg Time Held
Equity + Options
0.5
years
Top 20 Avg Time Held
Equity + Options
0.3
years
Avg Time Held Equity only
0.6
years
Top 10 Avg Time Held Equity only
0.7
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$7.98B |
| 2 |
Novanta Inc Units
NOVTU
|
+$1.24B |
| 3 |
PPL Corp Corporate Units
PPLC
|
+$1.11B |
| 4 |
NextEra Energy Inc 7.375% Corporate Units
NEE.PRV
|
+$1.08B |
| 5 |
Alibaba
BABA
|
+$405M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 2 |
Clearwater Analytics
CWAN
|
+$63.3M |
| 3 |
Amicus Therapeutics
FOLD
|
+$46.2M |
| 4 |
Sealed Air
SEE
|
+$38.6M |
| 5 |
Hologic
HOLX
|
+$35.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 86.78% |
| 2 | Technology | 4.48% |
| 3 | Consumer Discretionary | 3.01% |
| 4 | Industrials | 1.78% |
| 5 | Healthcare | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
451
GE Aerospace
GE
$307B
| $348K | ﹤0.01% |
930
-2,679
| -74% | -$839K |
2025 Q3
3 quarters
|
|
452
Royal Caribbean
RCL
$77.1B
| $347K | ﹤0.01% |
1,092
-1,661
| -60% | -$464K |
2025 Q4
2 quarters
|
|
453
CALL
Stryker
SYK
$114B
| $346K | ﹤0.01% |
1,100
-700
| -39% | -$221K |
2025 Q2
4 quarters
|
|
454
Ralph Lauren
RL
$22.7B
| $346K | ﹤0.01% |
+861
| New | +$320K |
2026 Q2
0 quarters
|
|
455
CALL
KeyCorp
KEY
$22.4B
| $343K | ﹤0.01% |
14,900
| – | – |
2026 Q1
1 quarter
|
|
456
CALL
Shell
SHEL
$300B
| $341K | ﹤0.01% |
4,400
| – | – |
2026 Q1
1 quarter
|
|
457
PUT
Tenet Healthcare
THC
$21.7B
| $337K | ﹤0.01% |
1,800
| – | – |
2026 Q1
1 quarter
|
|
458
CALL
US Bancorp
USB
$92B
| $332K | ﹤0.01% |
5,500
-2,100
| -28% | -$118K |
2025 Q2
4 quarters
|
|
459
PUT
ResMed
RMD
$34.6B
| $331K | ﹤0.01% |
1,700
-200
| -11% | -$41.5K |
2025 Q3
3 quarters
|
|
460
PUT
Cigna
CI
$80.4B
| $331K | ﹤0.01% |
1,200
-1,000
| -45% | -$283K |
2025 Q4
2 quarters
|
|
461
CALL
Lowe's Companies
LOW
$110B
| $331K | ﹤0.01% |
1,500
-900
| -38% | -$204K |
2025 Q1
5 quarters
|
|
462
PUT
Pentair
PNR
$8.44B
| $314K | ﹤0.01% |
4,100
| – | – |
2025 Q3
3 quarters
|
|
|
463
US Bancorp
USB
$92B
| $313K | ﹤0.01% |
+5,186
| New | +$291K |
2026 Q2
0 quarters
|
|
464
State Street Health Care Select Sector SPDR ETF
XLV
$46.5B
| $312K | ﹤0.01% |
1,964
-11,525
| -85% | -$1.71M |
2025 Q3
3 quarters
|
|
465
PUT
NXP Semiconductors
NXPI
$61.1B
| $309K | ﹤0.01% |
1,100
-10,100
| -90% | -$2.78M |
2025 Q2
4 quarters
|
|
466
Cameco
CCJ
$35.7B
| $306K | ﹤0.01% |
+3,000
| New | +$336K |
2026 Q2
0 quarters
|
|
467
PUT
Boston Properties
BXP
$9.36B
| $305K | ﹤0.01% |
4,600
| – | – |
2025 Q3
3 quarters
|
|
|
468
CALL
Cigna
CI
$80.4B
| $303K | ﹤0.01% |
1,100
-600
| -35% | -$170K |
2025 Q4
2 quarters
|
|
469
CALL
Ford
F
$47.5B
| $303K | ﹤0.01% |
21,800
-4,500
| -17% | -$60.7K |
2025 Q3
3 quarters
|
|
470
CALL
KLA
KLAC
$213B
| $302K | ﹤0.01% |
1,000
-2,000
| -67% | -$397K |
2025 Q1
5 quarters
|
|
471
PUT
Stellantis
STLA
$12.3B
| $301K | ﹤0.01% |
52,500
| – | – |
2026 Q1
1 quarter
|
|
472
CALL
Thermo Fisher Scientific
TMO
$257B
| $301K | ﹤0.01% |
600
-500
| -45% | -$240K |
2025 Q1
5 quarters
|
|
473
Berkshire Hathaway Class B
BRK.B
$1.15T
| $299K | ﹤0.01% |
597
-1,039
| -64% | -$499K |
2025 Q3
3 quarters
|
|
474
Procter & Gamble
PG
$364B
| $298K | ﹤0.01% |
2,035
-7,342
| -78% | -$1.07M |
2024 Q1
9 quarters
|
|
|
475
ResMed
RMD
$34.6B
| $297K | ﹤0.01% |
1,523
+220
| +17% | +$45.6K |
2025 Q3
3 quarters
|
|
Similar funds
Capula Management's Q2 2026 Portfolio in Review
As of Q2 2026, Capula Management held 1,190 positions worth $28B, up 99% from $14.1B the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Capula Management deployed $13.1B of net new capital in Q2 2026, opening 122 new positions and adding to 162 existing holdings. Its largest new stake was PPL Corp Corporate Units: 22,500,000 shares worth $11M.
By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, down from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.13B trimmed.
- Capula Management's largest Q2 2026 buy was PPL Corp Corporate Units: 22,500,000 shares worth $11M.
- Capula Management added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $7.98B increase.
- Capula Management's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.13B.
- Capula Management fully exited Clearwater Analytics in Q2 2026, selling an estimated $63.3M.
- Capula Management's ten largest holdings make up 73% of its $28B portfolio in Q2 2026.
- Capula Management opened 122 new positions and closed 490 in Q2 2026.
- Capula Management's portfolio value rose 99% quarter-over-quarter to $28B.
Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.